These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16146717)

  • 1. Inhibition of thrombin: relevance to anti-thrombosis strategy.
    Shen GX
    Front Biosci; 2006 Jan; 11():113-20. PubMed ID: 16146717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and current applications of thrombin-specific inhibitors.
    Shen GX
    Curr Drug Targets Cardiovasc Haematol Disord; 2001 Jun; 1(1):41-9. PubMed ID: 12769663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hirudin: clinical potential of a thrombin inhibitor.
    Johnson PH
    Annu Rev Med; 1994; 45():165-77. PubMed ID: 8198374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current developments in antithrombotic therapy: the role of antithrombin agents.
    Breddin HK
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 3():1-8. PubMed ID: 12811005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
    Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hirudin in heparin-induced thrombocytopenia.
    Lubenow N; Greinacher A
    Semin Thromb Hemost; 2002 Oct; 28(5):431-8. PubMed ID: 12420238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leeches to hirulogs and other thrombin-directed antithrombotics.
    Fenton JW
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1121-9. PubMed ID: 1400076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential advantages of direct-acting thrombin inhibitors.
    Philippides GJ; Loscalzo J
    Coron Artery Dis; 1996 Jul; 7(7):497-507. PubMed ID: 8913677
    [No Abstract]   [Full Text] [Related]  

  • 9. Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data.
    Direct Thrombin Inhibitor Trialists' Collaborative Group
    Lancet; 2002 Jan; 359(9303):294-302. PubMed ID: 11830196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction.
    French JK; Edmond JJ; Gao W; White HD; Eikelboom JW
    Am J Cardiovasc Drugs; 2004; 4(2):107-15. PubMed ID: 15049722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desirudin: a review of its use in the management of thrombotic disorders.
    Matheson AJ; Goa KL
    Drugs; 2000 Sep; 60(3):679-700. PubMed ID: 11030473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bivalirudin: a review of its potential place in the management of acute coronary syndromes.
    Carswell CI; Plosker GL
    Drugs; 2002; 62(5):841-70. PubMed ID: 11929334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective use of BCH-2763, a new potent injectable direct thrombin inhibitor, in combination with tissue plasminogen activator (tPA) in a rat arterial thrombolysis model.
    Deschênes I; Finkle CD; Winocour PD
    Thromb Haemost; 1998 Jul; 80(1):186-91. PubMed ID: 9684808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of venous thromboembolism following orthopaedic surgery: clinical potential of direct thrombin inhibitors.
    Eriksson BI; Dahl OE
    Drugs; 2004; 64(6):577-95. PubMed ID: 15018589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin.
    Bates SM; Weitz JI
    Am J Cardiol; 1998 Oct; 82(8B):12P-18P. PubMed ID: 9809887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct thrombin inhibitors for treatment of heparin induced thrombocytopenia, deep vein thrombosis and atrial fibrillation.
    Francis CW
    Curr Pharm Des; 2005; 11(30):3931-41. PubMed ID: 16305522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct antithrombins: mechanisms, trials, and role in contemporary interventional medicine.
    Wong CK; White HD
    Am J Cardiovasc Drugs; 2007; 7(4):249-57. PubMed ID: 17696566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hirudin as alternative anticoagulant--a historical review.
    Markwardt F
    Semin Thromb Hemost; 2002 Oct; 28(5):405-14. PubMed ID: 12420235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
    Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
    Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia.
    Lubenow N; Greinacher A
    Am J Cardiovasc Drugs; 2001; 1(6):429-43. PubMed ID: 14728002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.